Bradmer Announces Third Quarter 2017 Financial and Operational Results

TORONTO, ONTARIO -- (Marketwired) -- 11/06/17 -- Bradmer Pharmaceuticals Inc. (NEX: BMR.H) ("Bradmer" or the "Company") today announced its third quarter 2017 financial results.Financial ResultsAmounts in US dollars, unless specified otherwise, and results prepared in accordance with International Financial Reporting Standards ("IFRS").For the three months ended September 30, 2017, Bradmer recorded a net loss of $36,000 or $0.002 per common share based on the weighted average outstanding shares of 19,659,726 during the three month period, compared to a net loss [...]


read full post from firmenpresse

(161934 Posts)

Leave a Reply